Heron Therapeutics Inc.(HRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HRTX Heron Therapeutics Inc.

交易中 01-09 14:21:46 EST

1.42

+0.15

+11.42%

最高1.58	最低1.28	成交量610.15万
今开1.28	昨收1.27	日振幅23.23%
总市值2.59亿	流通市值2.16亿	总股本1.83亿
成交额902.85万	换手率3.99%	流通股本1.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HRTX","market":"US","secType":"STK","nameCN":"Heron Therapeutics Inc.","latestPrice":1.415,"timestamp":1767986498589,"preClose":1.27,"halted":0,"volume":6101521,"delay":0,"floatShares":153000000,"shares":183000000,"eps":-0.085973,"marketStatus":"交易中","change":0.145,"latestTime":"01-09 14:21:46 EST","open":1.28,"high":1.575,"low":1.28,"amount":9028534.1119906,"amplitude":0.232283,"askPrice":1.42,"askSize":1169,"bidPrice":1.41,"bidSize":5831,"shortable":3,"etf":0,"ttmEps":-0.085973,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1767992400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1390453200000,"exchange":"NASDAQ","adjPreClose":1.27,"preHourTrading":{"tag":"盘前","latestPrice":1.31,"preClose":1.27,"latestTime":"09:29 EST","volume":376,"amount":485.51996399999996,"timestamp":1767968954428},"postHourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.27,"latestTime":"18:45 EST","volume":9705,"amount":12327.87,"timestamp":1767915957102},"volumeRatio":5.167098,"impliedVol":1.748,"impliedVolPercentile":0.6733},"requestUrl":"/m/hq/s/HRTX","defaultTab":"news","newsList":[{"id":"1176610195","title":"Heron Therapeutics公布2025年第四季度及全年初步未经审计净营收 Zynrelef®成季度增长最大驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=1176610195","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176610195?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:30","pubTimestamp":1767969017,"startTime":"0","endTime":"0","summary":"Heron Therapeutics Inc. 近日披露了2025年第四季度及全年的初步未经审计净营收数据。根据初步统计，该公司在2025年第四季度实现了显著的收入增长，其中术后镇痛药物Zynrelef成为该季度业绩增长的最大贡献者。这一积极表现凸显了Zynrelef在市场中的强劲需求及其对公司整体营收的拉动作用。尽管面临市场竞争和行业挑战，Heron Therapeutics通过核心产品的商业化推进，保持了可持续的发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HRTX"],"gpt_icon":0},{"id":"1158507869","title":"Heron Therapeutics宣布Aponvie® (Aprepitant)注射乳剂纳入新发布的第五版围手术期恶心与呕吐管理共识指南","url":"https://stock-news.laohu8.com/highlight/detail?id=1158507869","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158507869?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:19","pubTimestamp":1764854351,"startTime":"0","endTime":"0","summary":"Heron Therapeutics宣布Aponvie® (Aprepitant)注射乳剂纳入新发布的第五版围手术期恶心与呕吐管理共识指南。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HRTX"],"gpt_icon":0},{"id":"2569976487","title":"Heron Therapeutics, Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569976487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569976487?lang=zh_cn&edition=full","pubTime":"2025-09-23 02:20","pubTimestamp":1758565204,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日02时20分，Heron Therapeutics, Inc.股票出现波动，股价大幅拉升5.28%。截至发稿，该股报1.30美元/股，成交量70.159万股，换手率0.38%，振幅6.91%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Mbx Biosciences, Inc.、Qualigen Therapeutics, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃，换手率分别为3399.24%、160.21%、71.55%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc，振幅分别为144.19%、86.84%、63.32%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923022005a72fde7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923022005a72fde7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2518920577","title":"Heron Therapeutics, Inc.盘中异动 下午盘快速下跌5.02%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518920577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518920577?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:42","pubTimestamp":1741628573,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时42分，Heron Therapeutics, Inc.股票出现波动，股价急速跳水5.02%。截至发稿，该股报2.27美元/股，成交量129.027万股，换手率0.85%，振幅6.07%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5340.63%、3824.56%、989.90%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014254a26a81c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014254a26a81c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","HRTX"],"gpt_icon":0},{"id":"2517430465","title":"Heron Therapeutics, Inc.2024财年实现净利润-13.58百万美元，同比增加87.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430465?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363243,"startTime":"0","endTime":"0","summary":"3月8日，Heron Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-13.58百万美元，同比增加87.77%；其中营业收入为1.44亿美元，同比增加13.39%，每股基本收益为-0.09美元。从资产负债表来看，Heron Therapeutics, Inc.总负债2.67亿美元，其中短期债务3.04百万美元，资产负债比为0.88，流动比率为0.03。机构评级：截至2025年3月8日，当前有4家机构对Heron Therapeutics, Inc.目标价做出预测，其中目标均价为6.25美元，其中最低目标价为4.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000139a2647ec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000139a2647ec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","LENZ"],"gpt_icon":0},{"id":"2516342886","title":"Heron Therapeutics, Inc.盘中异动 早盘股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516342886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516342886?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:38","pubTimestamp":1741012707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时38分，Heron Therapeutics, Inc.股票出现波动，股价快速跳水5.67%。截至发稿，该股报2.33美元/股，成交量37.9035万股，换手率0.25%，振幅5.06%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Geovax Labs, Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.65%、40.00%、31.61%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为23.25%、19.25%、18.04%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223828abe63577&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223828abe63577&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","HRTX"],"gpt_icon":0},{"id":"2514375311","title":"Heron Therapeutics, Inc.盘中异动 股价大涨5.12%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514375311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514375311?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:18","pubTimestamp":1740755904,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时18分，Heron Therapeutics, Inc.股票出现异动，股价快速上涨5.12%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Immunitybio, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1261.22%、401.27%、331.88%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、38.73%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231824989684c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231824989684c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","HRTX","BK4139"],"gpt_icon":0},{"id":"2514438556","title":"Heron Therapeutics, Inc.盘中异动 急速拉升8.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514438556?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666726,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Heron Therapeutics, Inc.股票出现异动，股价快速拉升8.77%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、天演药业涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为410.42%、91.10%、50.47%，振幅较大的相关个股有天演药业、Pds Biotechnology Corporation、曼恩凯德生物医疗，振幅分别为13.13%、11.69%、10.24%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223206a2567a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223206a2567a0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","HRTX","BK4139"],"gpt_icon":0},{"id":"2514801979","title":"Heron Therapeutics(HRTX.US)：2024年Q4财报实现营收4078.1万美元，前值为3423.3万美元，预期值为3737万美元；每股收益为0.02美元，前值为-0.07美元，预期值为-0.03美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801979","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801979?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:51","pubTimestamp":1740660669,"startTime":"0","endTime":"0","summary":"Heron Therapeutics(HRTX.US)：2024年Q4财报实现营收4078.1万美元，前值为3423.3万美元，预期值为3737万美元；每股收益为0.02美元，前值为-0.07美元，预期值为-0.03美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27205148437296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HRTX","LENZ"],"gpt_icon":0},{"id":"1176545575","title":"Heron Therapeutics预期2025年销售额为1.53亿至1.63亿美元，对比预期为1.60633亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176545575","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176545575?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:50","pubTimestamp":1740660648,"startTime":"0","endTime":"0","summary":"2025年财务指引，Heron Therapeutics预计全年净收入为1.53亿至1.63亿美元。调整后的EBITDA预计将在0到800万美元之间。以上内容来自Benzinga Earnings专栏，原文如下：Financial Guidance for 2025 Item2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA(in millions)Net Revenue$153.0to$163.0Adjusted EBITDA$0.0to$8.0","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX"],"gpt_icon":0},{"id":"1132168551","title":"Heron Therapeutics 2024年第四季度GAAP每股收益$0.02超出$(0.03)预期，销售额$40.78M超过$37.37M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1132168551","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132168551?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:50","pubTimestamp":1740660645,"startTime":"0","endTime":"0","summary":"Heron Therapeutics报告季度每股收益为$0.02，超出分析师一致预期的$，上涨166.67%。公司报告的季度销售额为$40.78M，超出分析师预期的$37.37M，增长了9.14%。相比去年同期的$34.23M，销售额增长了19.13%。以上内容来自Benzinga Earnings专栏，原文如下：Heron $Therapeutics$  reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $ by 166.67 percent. This is a 128.57 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $40.78 million which beat the analyst consensus estimate of $37.37 millio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Heron Therapeutics 2024年第四季度GAAP每股收益$0.02超出$(0.03)预期，销售额$40.78M超过$37.37M预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX"],"gpt_icon":0},{"id":"2514851095","title":"Heron Therapeutics, Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851095?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:51","pubTimestamp":1740581510,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时51分，Heron Therapeutics, Inc.股票出现异动，股价大幅上涨5.36%。截至发稿，该股报1.77美元/股，成交量15.9569万股，换手率0.10%，振幅2.98%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Cns Pharmaceuticals, Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4236.29%、150.76%、127.50%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为127.12%、38.41%、29.31%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225150abddf22b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225150abddf22b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","HRTX"],"gpt_icon":0},{"id":"2514011285","title":"Heron Therapeutics, Inc.盘中异动 快速跳水5.05%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514011285?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:32","pubTimestamp":1740501153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时32分，Heron Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1386.01%、1116.06%、913.58%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260032339892661b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260032339892661b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","HRTX"],"gpt_icon":0},{"id":"2511696289","title":"Heron Therapeutics, Inc.盘中异动 急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696289?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:34","pubTimestamp":1739543667,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时34分，Heron Therapeutics, Inc.股票出现波动，股价快速上涨5.45%。截至发稿，该股报1.74美元/股，成交量3.4735万股，换手率0.02%，振幅4.85%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1076.96%、375.03%、345.36%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.、Theratechnologies Inc.，振幅分别为20.20%、19.73%、18.33%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422342798858a25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422342798858a25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","HRTX"],"gpt_icon":0},{"id":"2508680654","title":"Heron Therapeutics, Inc.盘中异动 股价大涨5.33%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508680654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508680654?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:19","pubTimestamp":1738682399,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时19分，Heron Therapeutics, Inc.股票出现波动，股价大幅上涨5.33%。截至发稿，该股报1.78美元/股，成交量9.7861万股，换手率0.06%，振幅5.33%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1475.03%、871.94%、220.42%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Viracta Therapeutics, Inc.，振幅分别为64.17%、49.87%、44.22%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231959a2393275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231959a2393275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2507672472","title":"Heron Therapeutics, Inc.盘中异动 下午盘急速拉升5.39%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507672472?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:24","pubTimestamp":1738265040,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时24分，Heron Therapeutics, Inc.股票出现异动，股价大幅拉升5.39%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1789.73%、305.81%、246.01%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、64.10%、61.86%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310324019876d0ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310324019876d0ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","HRTX","BK4139"],"gpt_icon":0},{"id":"2506893061","title":"Heron Therapeutics, Inc.盘中异动 急速拉升5.11%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506893061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506893061?lang=zh_cn&edition=full","pubTime":"2025-01-25 01:18","pubTimestamp":1737739084,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日01时18分，Heron Therapeutics, Inc.股票出现异动，股价快速拉升5.11%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4028.57%、2208.09%、1634.18%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Celularity Inc C/Wts 16/07/2026 ，振幅分别为134.08%、112.09%、69.09%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125011805a22e7d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125011805a22e7d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","HRTX","BK4139"],"gpt_icon":0},{"id":"2505043910","title":"Heron Therapeutics, Inc.盘中异动 早盘股价大涨5.21%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505043910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505043910?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:16","pubTimestamp":1737648979,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时16分，Heron Therapeutics, Inc.股票出现波动，股价快速上涨5.21%。截至发稿，该股报1.72美元/股，成交量32.7628万股，换手率0.22%，振幅5.52%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3537.07%、1536.40%、650.36%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为186.07%、64.29%、55.57%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001619a22d1ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001619a22d1ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","HRTX","BK4139"],"gpt_icon":0},{"id":"2504164750","title":"Heron Therapeutics, Inc.盘中异动 早盘快速拉升5.10%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504164750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504164750?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:36","pubTimestamp":1737124619,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时36分，Heron Therapeutics, Inc.股票出现异动，股价大幅拉升5.10%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Revolution Medicines Inc C/Wts 17/12/2026 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为101.03%、15.66%、8.61%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为44.21%、31.14%、25.64%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223659986a1647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223659986a1647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2503227684","title":"Heron Therapeutics, Inc.盘中异动 临近收盘股价大跌5.19%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503227684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503227684?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:55","pubTimestamp":1736888103,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时55分，Heron Therapeutics, Inc.股票出现波动，股价大幅下跌5.19%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1102.05%、630.51%、424.81%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115045503abab01ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115045503abab01ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HRTX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.herontx.com","stockEarnings":[{"period":"1week","weight":-0.0231},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0078},{"period":"6month","weight":-0.4174},{"period":"1year","weight":-0.2063},{"period":"ytd","weight":-0.0231}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.1057},{"period":"1year","weight":0.1697},{"period":"ytd","weight":0.0111}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Heron Therapeutics, Inc.该公司于1983年2月在加利福尼亚州成立，当时的名称为AMCO Polymerics公司（AMCO）。AMCO公司于1984年更名为Advanced Polymer Systems公司，并于1987年在特拉华州重新合并成立。该公司于2001年5月更名为AP制药公司，以反映其新的药品重点，是一家商业阶段的生物技术公司，专注于通过开发和商业化改善医疗保健的治疗创新来改善患者的生活。该公司的主要重点是其领先候选产品，APF530，该产品是为用于预防化疗引起的恶心和呕吐（CINV）而开发。该公司的核心Biochronomer技术包括旨在规定时间内释放药物的可生物腐蚀聚合物，其APF530和其他候选产品都是基于该技术而研发。该公司已完成100多项体内和体外研究，研究结果表明，该公司的Biochronomer技术可能适用于多种治疗领域，包括预防恶心和呕吐，疼痛管理，炎症的控制与眼科疾病的治疗。该公司还完成了全面的动物和人体毒理学研究，并得出结论——其Biochronomer聚合物是安全的，并具有良好的耐受性。此外，该公司的Biochronomer技术可以用于在几天或几个月内释放药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.004042},{"month":2,"riseRate":0.5,"avgChangeRate":0.063139},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.038602},{"month":4,"riseRate":0.583333,"avgChangeRate":0.029111},{"month":5,"riseRate":0.333333,"avgChangeRate":0.014053},{"month":6,"riseRate":0.666667,"avgChangeRate":0.054669},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.02215},{"month":8,"riseRate":0.583333,"avgChangeRate":0.018359},{"month":9,"riseRate":0.25,"avgChangeRate":-0.098063},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.043598},{"month":11,"riseRate":0.583333,"avgChangeRate":0.052026},{"month":12,"riseRate":0.5,"avgChangeRate":0.066572}],"exchange":"NASDAQ","name":"Heron Therapeutics Inc.","nameEN":"Heron Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Heron Therapeutics Inc.(HRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Heron Therapeutics Inc.(HRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Heron Therapeutics Inc.,HRTX,Heron Therapeutics Inc.股票,Heron Therapeutics Inc.股票老虎,Heron Therapeutics Inc.股票老虎国际,Heron Therapeutics Inc.行情,Heron Therapeutics Inc.股票行情,Heron Therapeutics Inc.股价,Heron Therapeutics Inc.股市,Heron Therapeutics Inc.股票价格,Heron Therapeutics Inc.股票交易,Heron Therapeutics Inc.股票购买,Heron Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Heron Therapeutics Inc.(HRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Heron Therapeutics Inc.(HRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}